Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From accepting to distancing as different coping strategies in persons with young onset Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

When physicians become patients: A podcast series for learning from patient experiences.

PEC innovation·2025
Same author

Challenges and recommendations for high quality research using electronic health records.

Frontiers in digital health·2022
Same author

The course of post-stroke apathy in relation to cognitive functioning: a prospective longitudinal cohort study.

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition·2021
Same author

Long-term neurologic and cognitive outcome and quality of life in adults after pneumococcal meningitis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Training residents in patient-centred communication and empathy: evaluation from patients, observers and residents.

BMC medical education·2019

Related Experiment Video

Updated: Jul 11, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Motor procedural learning in Parkinson's disease.

D Muslimovic1, B Post, J D Speelman

  • 1Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands. d.muslimovic@amc.uva.nl

Brain : a Journal of Neurology
|September 15, 2007
PubMed
Summary

Parkinson's disease (PD) patients show a small deficit in acquiring sequence-specific knowledge, but this procedural learning impairment does not affect their functional status. This deficit emerges later in the disease, independent of cognitive issues.

More Related Videos

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Related Experiment Videos

Last Updated: Jul 11, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Science

Background:

  • The striatum is implicated in motor procedural learning.
  • Previous studies on Parkinson's disease (PD) and procedural learning have yielded inconsistent results.
  • The functional impact of procedural learning impairment in PD remains unclear.

Purpose of the Study:

  • To investigate the effects of Parkinson's disease on procedural learning.
  • To determine if impaired procedural learning impacts functional status in PD patients.

Main Methods:

  • Compared 95 non-demented PD patients with 44 controls on the serial reaction time task (SRTT).
  • Assessed declarative memory, executive, and visuospatial functions.
  • Quantitatively rated functional outcomes in PD patients.

Main Results:

  • PD patients showed a small, but significant, inefficiency in acquiring sequence-specific knowledge compared to controls (d = 0.38).
  • No difference in learning rate was observed across blocks of repeating sequence trials.
  • Impaired procedural learning did not correlate with cognitive measures or affect functional status.
  • Early-stage, non-medicated PD patients showed no SRTT performance differences.

Conclusions:

  • Procedural learning impairment is not an early feature of PD.
  • Deficits in motor sequence learning likely emerge with disease progression.
  • The observed impairment is independent of cognitive dysfunction or dopaminergic medication.